Can I read Capecitabine for Metastatic Nasopharyngeal Cancer on EtoBox?

Capecitabine for Metastatic Nasopharyngeal Cancer by trifamonika23 is a document available to read on EtoBox.

What is Capecitabine for Metastatic Nasopharyngeal Cancer about?

This study evaluated the efficacy and safety of capecitabine monotherapy in 49 patients with recurrent or metastatic nasopharyngeal carcinoma. Most patients had received prior platinum-based chemotherapy. The overall response rate to capecitabine was 37%, with a median time to progression of 5 months and median survival of 14 months. Treatment was generally well tolerated, with the most common toxicity being hand-foot syndrome in 86% of patients. Severe hand-foot syndrome was associated with better survival

Author

trifamonika23

Language

EN